Similar major cardiovascular outcomes between pure statin and ezetimibe-statin in comparable intensity for type 2 diabetes with extremely atherosclerotic risks

Atorvastatin 40 mg (ATOR 40) and ezetimibe 10 mg/simvastatin 20 mg (EZ-SIM 20) have similar reductions of low-density lipoprotein cholesterol (LDL-C) but cardiovascular (CV) outcomes between these two therapies are unclear. Our real-world cohort study is to test the hypothesis of pleiotropic effects...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Sci Rep
Main Authors: Kao, Yu-Cheng, Chen, Tien-Hsing, Liu, Chi-Hung, Hwang, Jawl-Shan, Hsiao, Ching-Chung, Lin, Yu-Sheng, Mao, Chun-Tai, Hung, Ming-Jui, Li, Yan-Rong
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group UK 2021
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7988142/
https://ncbi.nlm.nih.gov/pubmed/33758291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-86090-9
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki